News

Syngas is the key precursor for the production of oxo intermediates and oxo derivatives, which are used in pharmaceutical products. The manufacturing facility develops oxo chemicals, synthetic fatty

The US Department of Health and Human Services for the Influenza Division of the National Center for Immunization and Respiratory Diseases (NCIRD) has offered to fund the research.

The delivery system will be based upon TriLogic drug delivery platform TRI-726 and will be licensed to Mission Pharmacal for future drug development with focus on women’s health

Silenor is used for the treatment of insomnia characterized by difficulty with sleep maintenance. According to the company, FDA provided clinical and regulatory guidance is believed to help

The CFCs present in the product deplete the earth’s ozone layer. The decision follows the Montreal Protocol treaty to stop the use of substances that damage the environment.

BioThrax vaccine is licensed by the US Food and Drug Administration (FDA) to protect against anthrax infection. Under this award, the initial deliveries are likely to begin in

Benefix RTS can be stored for up to two years at room temperature (2-30°C) for about two years, thereby providing more convenience to haemophilia B patients, europeanpharmaceuticalreview reported.

The settlement includes a license by MDCO to Teva and its affiliates under which Teva may launch a generic bivalirudin product. Teva admits that the two patents asserted

Cleviprex is an intravenous dihydropyridine calcium channel blocker, which helps in reduction of blood pressure when oral therapy is not feasible. According to the company, the new formulation